The verification study for neurocognitive status improvement: A randomized double-blind placebo-controlled trial
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000026297
- Lead Sponsor
- ORTHOMEDICO Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Not provided
1. At least one previous medical history of malignant tumor, heart failure or myocardial infarction 2. Currently under the treatment for either cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension or other chronic diseases 3. Those who have dementia 4. Those who have depression disorder, ADHD, or etc. such as mental illness 5. Those who use or take "Foods for Specified Health Uses" and "Foods with Functional Claims" in daily 6. Currently taking medicines and/or herbal medicines 7. Those who take DHA or/and EPA-containing food in daily 8. Those who are allergic to medicines and/or the test food related products 9. Those who are pregnant, breast-feeding, and plan to become a pregnant 10. Those who had participated another clinical test for three months when you signed the informed consent form for this trial 11. Others considered as inappropriate for the study by the physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Neuropsychological tests (Cognitrax)
- Secondary Outcome Measures
Name Time Method 1. Dementia Assessment Sheet in Community-based Integrated Care System (DASC-21) 2. Original questionnaire (Likert scale)